![logo](/logos/MIRM.webp)
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
41.12 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Mirum Pharmaceuticals, Inc. |
Symbool | MIRM |
Munteenheid | USD |
Prijs | 41.12 |
Beurswaarde | 1,961,720,064 |
Dividendpercentage | 0% |
52-weken bereik | 23.14 - 45.23 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christopher Peetz |
Website | https://www.mirumpharma.com |
An error occurred while fetching data.
Over Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)